Transcription factor E2F-1 is upregulated in human gastric cancer tissues and its overexpression suppresses gastric tumor cell proliferation

Cellular Oncology

Volumn 29, Issue 4, 2007, Pages 335-349

  Xiao, Qiang ^a   Li, Lei ^a   Xie, Yubo ^a   Tan, Ning ^a   Wang, Changqing ^a   Xu, Junyi ^a   Xia, Keyi ^a   Gardner, Kevin ^b   Li, Qingdi Q ^b  

^a GUANGXI MEDICAL UNIVERSITY   (China)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Cell cycle; Cell growth; Cell proliferation; Cell survival; E2F 1; Gastric cancer; Human tissues; MKN 45 cells; Mutation

Indexed keywords

ARTICLE; CANCER GROWTH; CORRELATION ANALYSIS; GENE FUNCTION; GENE MUTATION; GENE OVEREXPRESSION; GENETIC ANALYSIS; HUMAN; IMMUNOHISTOCHEMISTRY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SINGLE STRAND CONFORMATION POLYMORPHISM; STOMACH CANCER; STOMACH CARCINOMA; STOMACH MUCOSA; UPREGULATION;

ADULT; AGED; ANIMALS; CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; CERCOPITHECUS AETHIOPS; COS CELLS; E2F1 TRANSCRIPTION FACTOR; FEMALE; GENE EXPRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC VECTORS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MUTATION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; STOMACH; STOMACH NEOPLASMS; TRANSFECTION; UP-REGULATION;

EID: 34447133539     PISSN: 15705870     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (65)

1. I. Kovesdi, R. Reichel and J.R. Nevins, Identification of a cellular transcription factor involved in E1A trans-activation, Cell 45 (1986), 219-282.
2. N. Dyson, The regulation of E2F by pRB-family proteins, Genes Dev. 12 (1998), 2245-2262.
3. J.R. Nevins, Toward an understanding of the functional complexity of the E2F and retinoblastoma families, Cell Growth Differ. 9 (1998), 585-593.
4. H. Muller and K. Helin, The E2F transcription factors: key regulators of cell proliferation, Biochim. Biophys. Acta. 1470 (2000), M1-M12.
5. J.R. Nevins, The Rb/E2F pathway and cancer, Hum. Mol. Genet. 10 (2001), 699-703.
6. A.C. Phillips and K.H. Vousden, E2F-1 induced apoptosis, Apoptosis 6 (2001) 173-182.
7. O. Loughran and N.B. La Thangue, E2F proteins, Curr. Biol. 12 (2002) R377.
8. O. Stevaux and N.J. Dyson, A revised picture of the E2F transcriptional network and RB function, Curr. Opin. Cell. Biol. 14 (2002) 684-691.
9. J.M. Trimarchi and J.A. Lees, Sibling rivalry in the E2F family, Nat. Rev. Mol. Cell. Biol. 3 (2002), 11-20.
10. J.W. Harbour and D.C. Dean, The Rb/E2F pathway: expanding roles and emerging paradigms, Genes. Dev. 14 (2000), 2393-2409.
11. A.R. Black and J. Azizkhan-Clifford, Regulation of E2F: a family of transcription factors involved in proliferation control, Gene 237 (1999), 281-302.
12. A.H. Wyllie, E2F1 selects tumour cells for both life and death, J. Pathol. 198 (2002), 139-141.
13. L.A. Bell and K.M. Ryan, Life and death decisions by E2F-1, Cell Death Differ. 11 (2004), 137-142.
14. K. Helin, Regulation of cell proliferation by the E2F transcription factors, Curr. Opin. Genet. Dev. 8 (1998), 28-35.
15. D.G. Johnson, J.K. Schwarz, W.D. Cress and J.R. Nevins, Expression of transcription factor E2F1 induces quiescent cells to enter S phase, Nature 365 (1993), 349-352.
16. G. Xu, D.M. Livingston and W. Krek, Multiple members of the E2F transcription factor family are the products of oncogenes, Proc. Natl. Acad. Sci. USA 92 (1995), 1357-1361.
17. A.M. Pierce, S.M. Fisher, C.J. Conti and D.G. Johnson, Deregulated expression of E2F1 induces hyperplasia and cooperates with ras in skin tumor development, Oncogene 16 (1998), 1267-1276.
18. T. Suzuki, W. Yasui, H. Yokozaki, K. Naka, T. Ishikawa and E. Tahara, Expression of the E2F family in human gastrointestinal carcinomas, Int. J. Cancer 81 (1999), 535-538.
19. W. Yasui, K. Naka, T. Suzuki, J. Fujimoto, K. Hayashi, N. Matsutani, H. Yokozaki and E. Tahara, Expression of p27Kip1, cyclin E and E2F-1 in primary and metastatic tumors of gastric carcinoma, Oncol. Rep. 6 (1999), 983-987.
20. W. Yasui, H. Yokozaki, J. Fujimoto, K. Naka, H. Kuniyasu and E. Tahara, Genetic and epigenetic alterations in multistep carcinogenesis of the stomach, J. Gastroenterol. 35 (2000), 111-115.
21. S.Y. Zhang, S.C. Liu, D.G. Johnson and A.J. Klein-Szanto, E2F-1 gene transfer enhances invasiveness of human head and neck carcinoma cell lines, Cancer. Res. 60 (2000), 5972-5976.
22. T.F. Kowalik, J. DeGregori, J.K. Schwarz and J.R. Nevins, E2F1 overexpression in quiescent fibroblasts leads to induction of cellular DNA synthesis and apoptosis, J. Virol. 69 (1995), 2491-2500.
23. S.J. Field, F.Y. Tsai, F. Kuo, A.M. Zubiaga, W.G. Kaelin Jr., D.M. Livingston, S.H. Orkin and M.E. Greenberg, E2F-1 functions in mice to promote apoptosis and suppress proliferation, Cell 85 (1996), 549-561.
24. C. Atienza Jr., M.J. Elliott, Y.B. Dong, H.L. Yang, A. Stilwell, T.J. Liu and K.M. McMasters, Adenovirus-mediated E2F-1 gene transfer induces an apoptotic response in human gastric carcinoma cells that is enhanced by cyclin dependent kinase inhibitors, Int. J. Mol. Med. 6 (2000), 55-63.
25. L. Yamasaki, T. Jacks, R. Bronson, E. Goillot, E. Harlow and N.J. Dyson, Tumor induction and tissue atrophy in mice lacking E2F-1, Cell 85 (1996), 537-548.
26. H. Pan, C. Yin, N.J. Dyson, E. Harlow, L. Yamasaki and T. Van Dyke, Key roles for E2F1 in signaling p53-dependent apoptosis and in cell division within developing tumors, Mol. Cell 2 (1998), 283-292.
27. L. Yamasaki, R. Bronson, B.O. Williams, N.J. Dyson, E. Harlow and T. Jacks, Loss of E2F-1 reduces tumorigenesis and extends the lifespan of Rb1(+/-) mice, Nat. Genet. 18 (1998), 360-364.
28. B. Shan and W.H. Lee, Deregulated expression of E2F-1 induces S-phase entry and leads to apoptosis, Mol. Cell Biol. 14 (1994), 8166-8173.
29. W. Krek, G. Xu and D.M. Livingston, Cyclin A-kinase regulation of E2F-1 DNA binding function underlies suppression of an S phase checkpoint, Cell 83 (1995), 1149-1158.
30. T.J. Logan, D.L. Evans, W.E. Mercer, M.A. Bjornsti and D.J. Hall, Expression of a deletion mutant of the E2F1 transcription factor in fibroblasts lengthens S phase and increases sensitivity to S phase-specific toxins, Cancer Res. 55 (1995), 2883-2891.
31. L. Farhana, M. Dawson, A.K. Rishi, Y. Zhang, E. Van Buren, C. Trivedi, U. Reichert, G. Fang, M.W. Kirschner and J.A. Fontana, Cyclin B and E2F-1 expression in prostate carcinoma cells treated with the novel retinoid CD437 are regulated by the ubiquitin-mediated pathway, Cancer Res. 62 (2002), 3842-3849.
32. S.K. Radhakrishnan, C.S. Feliciano, F. Najmabadi, A. Haegebarth, E.S. Kandel, A.L. Tyner and A.L. Gartel, Constitutive expression of E2F-1 leads to p21-dependent cell cycle arrest in S phase of the cell cycle, Oncogene 23 (2004), 4173-4176.
33. V.G. Gorgoulis, P. Zacharatos, G. Mariatos, A. Kotsinas, M. Bouda, D. Kletsas, P.J. Asimacopoulos, N. Agnantis, C. Kittas and A.G. Papavassiliou, Transcription factor E2F-1 acts as a growth-promoting factor and is associated with adverse prognosis in non-small cell lung carcinomas, J. Pathol. 198 (2002), 142-156.
34. B. Eymin, S. Gazzeri, C. Brambilla and E. Brambilla, Distinct pattern of E2F1 expression in human lung tumours: E2F1 is upregulated in small cell lung carcinoma, Oncogene 20 (2001), 1678-1687.
35. M.B. Moller, P.W. Kania, Y. Ino, A.M. Gerdes, O. Nielsen, D.N. Louis, K. Skjodt and N.T. Pedersen, Frequent disruption of the RB1 pathway in diffuse large B cell lymphoma: prognostic significance of E2F-1 and p16INK4A, Leukemia 14 (2000), 898-904.
36. C.S. Wilson, A.W. Butch, R. Lai, L.J. Medeiros, J.R. Sawyer, B. Barlogie, A. McCourty, K. Kelly and R.K. Brynes, Cyclin D1 and E2F-1 immunoreactivity in bone marrow biopsy specimens of multiple myeloma: relationship to proliferative activity, cytogenetic abnormalities and DNA ploidy, Br. J. Haematol. 112 (2001), 776-782.
37. A.D. Saiz, M. Olvera, S. Rezk, B.A. Florentine, A. McCourty and R.K. Brynes, Immunohistochemical expression of cyclin D1, E2F-1, and Ki-67 in benign and malignant thyroid lesions, J. Pathol. 198 (2002), 157-162.
38. K. Yamazaki, A unique pancreatic ductal adenocarcinoma with carcinosarcomatous histology, immunohistochemical distribution of hCG-β, and the elevation of serum α-fetoprotein, J. Submicrosc. Cytol. Pathol. 35 (2003), 343-349.
39. K. Yamazaki, M. Hasegawa, I. Ohoka, K. Hanami, A. Asoh, T. Nagao, I. Sugano and Y. Ishida, Increased E2F-1 expression via tumour cell proliferation and decreased apoptosis are correlated with adverse prognosis in patients with squamous cell carcinoma of the oesophagus, J. Clin. Pathol. 58 (2005), 904-910.
40. P. Zacharatos, A. Kotsinas, K. Evangelou, P. Karakaidos, L.V. Vassiliou, N. Rezaei, A. Kyroudi, C. Kittas, E. Patsouris, A.G. Papavassiliou and V.G. Gorgoulis, Distinct expression patterns of the transcription factor E2F-1 in relation to tumour growth parameters in common human carcinomas, J. Pathol. 203 (2004), 744-753.
41. L. Yang, Incidence and mortality of gastric cancer in China, World J. Gastroenterol. 12 (2006), 17-20.
42. J.M. Elias, A.M. Gown, R.M. Nakamura, D.C. Wilbur, G.E. Herman, E.S. Jaffe, H. Battifora and D.J. Brigati, Quality control in immunohistochemistry. Report of a workshop sponsored by the Biological Stain Commission, Am. J. Clin. Pathol. 92 (1989), 836-843.
43. A.M. Pierce, R. Schneider-Broussard, I.B. Gimenez-Conti, J.L. Russell, C.J. Conti and D.G. Johnson, E2F1 has both oncogenic and tumor-suppressive properties in a transgenic model, Mol. Cell. Biol. 19 (1999), 6408-6414.
44. H. Ishii, K. Mimori, Y. Yoshikawa, M. Mori, Y. Furukawa and A. Vecchione, Differential roles of E-type cyclins during transformation of murine E2F-1-deficient cells, DNA Cell. Biol. 24 (2005), 173-179.
45. C. Park, I. Lee and W.K. Kang, E2F-1 is a critical modulator of cellular senescence in human cancer, Int. J. Mol. Med. 17 (2006), 715-720.
46. N.B. La Thangue, The yin and yang of E2F-1: balancing life and death, Nat. Cell. Biol. 5 (2003), 587-589.
47. X.H. Yang and T.L. Sladek, Overexpression of the E2F-1 transcription factor gene mediates cell transformation, Gene Expr. 4 (1995), 195-204.
48. F. Rabbani, V.M. Richon, I. Orlow, M.L. Lu, M. Drobnjak, M. Dudas, E. Charytonowicz, G. Dalbagni and C. Cordon-Cardo, Prognostic significance of transcription factor E2F-1 in bladder cancer: genotypic and phenotypic characterization, J. Natl. Cancer Inst. 91 (1999), 874-881.
49. G.H. Ho, J.E. Calvano, M. Bisogna and K.J. Van Zee, Expression of E2F-1 and E2F-4 is reduced in primary and metastatic breast carcinomas, Breast Cancer Res. Treat. 69 (2001), 115-122.
50. S.Y. Zhang, S.C. Liu, L.F. Al-Saleem, D. Holloran, J. Babb, X. Guo and A.J. Klein-Szanto, E2F-1:a proliferative marker of breast neoplasia, Cancer Epidemiol. Biomarkers Prev. 9 (2000), 395-401.
51. K.K. Hunt, J. Deng, T.J. Liu, M. Wilson-Heiner, S.G. Swisher, G. Clayman and M.C. Hung, Adenovirus-mediated overexpression of the transcription factor E2F-1 induces apoptosis in human breast and ovarian carcinoma cell lines and does not require p53, Cancer Res. 57 (1997), 4722-4726.
52. J. Fueyo, C. Gomez-Manzano, W.K. Yung, T.J. Liu, R. Alemany, T.J. McDonnell, X. Shi, J.S. Rao, V.A. Levin and A.P. Kyritsis, Overexpression of E2F-1 in glioma triggers apoptosis and suppresses tumor growth in vitro and in vivo, Nat. Med. 4 (1998), 685-690.
53. M.J. Elliott, Y.B. Dong, H. Yang and K.M. McMasters, E2F-1 up-regulates c-Myc and p14(ARF) and induces apoptosis in colon cancer cells, Clin. Cancer. Res. 7 (2001), 3590-3597.
54. M.J. Elliott, M.R. Farmer, C. Atienza Jr., A. Stilwell, Y.B. Dong, H.L. Yang, S.L. Wong and K.M. McMasters, E2F-1 gene therapy induces apoptosis and increases chemosensitivity in human pancreatic carcinoma cells, Tumour Biol. 23 (2002), 76-86.
55. ARF links the tumour suppressor RB and p53, Nature 395 (1998), 124-125.
56. M.C. Moroni, E.S. Hickman, E.L. Denchi, G. Caprara, E. Colli, F. Cecconi, H. Muller and K. Helin, Apaf-1 is a transcriptional target for E2F and p53, Nat. Cell. Biol. 3 (2001), 552-558.
57. M. Irwin, M.C. Martin, A.C. Phillips, R.S. Seelan, D.I. Smith, W. Liu, E.R. Flores, K.Y. Tsai, T. Jacks, K.H. Vousden and W.G. Kaelin Jr., Role for the p53 homologue p73 in E2F-1-induced apoptosis, Nature 407 (2000), 645-648.
58. N.A. Lissy, P.K. Davis, M. Irwin, W.G. Kaelin and S.F. Dowdy, A common E2F-1 and p73 pathway mediates cell death induced by TCR activation, Nature 407 (2000), 642-644.
59. Y. Furukawa, N. Nashimura, Y. Furukawa, M. Satoh, H. Endo, S. Iwase, H. Yamada, M. Matsuda, Y. Kano and M. Nakamura, Apaf-1 is a mediator of E2F-1 induced apoptosis, J. Biol. Chem. 277 (2002), 39760-39768.
60. Z. Nahle, J. Polakoff, R.V. Davuluri, M.E. McCurrach, M.D. Jacobson, M. Narita, M.Q. Zhang, Y. Lazebnik, D. Bar-Sagi and S.W. Lowe, Direct coupling of the cell cycle and cell death machinery by E2F, Nat. Cell. Biol. 4 (2002), 859-864.
61. M. Karin and A. Lin, NF-κB at the crossroads of life and death, Nat. Immunol. 3 (2002), 221-227.
62. H. Tanaka, I. Matsumura, S. Ezoe, Y. Satoh, T. Sakamaki, C. Albanese, T. Machii, R.G. Pestell and Y. Kanakura, E2F1 and c-Myc potentiate apoptosis through inhibition of NF-κB activity that facilitates MnSOD-mediated ROS elimination, Mol. Cell 9 (2002), 1017-1029.
63. A. Brehm, E.A. Miska, D.J. McCance, J.L. Reid, A.J. Bannister and T. Kouzarides, Retinoblastoma protein recruits histone deacetylase to repress transcription, Nature 391 (1998), 597-601.
64. F. Martelli, T. Hamilton, D.P. Silver, N.E. Sharpless, N. Bardeesy, M. Rokas, R.A. DePinho, D.M. Livingston and S.R. Grossman, p19ARF targets certain E2F species for degradation, Proc. Natl. Acad. Sci. USA 98 (2001), 4455-4460.
65. M.R. Campanero and E.K. Flemington, Regulation of E2F through ubiquitin-proteasome-dependent degradation: stabilization by the pRB tumor suppressor protein, Proc. Natl. Acad. Sci. USA 94 (1997), 2221-2226.